Company Website

Contact Information:
Kelly Bowman
kbowman@esperion.com
734-309-8041

Virtual Exhibit Hall Home

Esperion Therapeutics is The Lipid Management Company. Our team of lipid experts works to lower bad cholesterol by discovering, developing and commercializing innovative medicines and combinations with established medicines. Our products, NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, non-statins used with diet & maximally tolerated statins to treat adults with HeFH or ASCVD needing added LDL-C lowering. The effect on cardiovascular morbidity/mortality has not been determined. Contraindication for NEXLIZET is known hypersensitivity to ezetimibe. Warnings: NEXLETOL/NEXLIZET increase risk of hyperuricemia & tendon rupture. www.nexletolhcp.com/risk
Please see full Prescribing Information for NEXLIZET and NEXLETOL at https://www.nexlizethcp.com/

To submit a medical question, contact the Esperion Medical Information at 1-833-377-7633 or email us at medinfo@epserion.com

To find out more about our products, please contact Kelly Bowman at kbowman@esperion.comor Phone 734-309-8041
 

Additional Information
NEXLIZET HCP Brochure 
Important Safety Information